Infertility rates are driving growth in the Regranex Market 2026

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Large Is The Rekovelle Market Projected To Become By 2030 Based On Its 2026 Valuation?

The historical growth was influenced by a rise in infertility rates, an increase in assisted reproductive technology clinics, a trend towards higher maternal age, greater access to fertility medications, and the clinical approval of recombinant hormone therapies.

The anticipated growth during the forecast period is a result of several factors, such as the rising need for IVF treatments, a stronger inclination towards tailored fertility solutions, the broadening reach of fertility tourism, increased funding in reproductive health, and ongoing advancements in hormonal stimulation methods.

Key developments expected in the forecast period involve a greater uptake of customized fertility interventions, an increase in the application of recombinant gonadotropins, a heightened emphasis on unique ovarian stimulation plans for individuals, a growth in the total number of IVF treatments, and improved accuracy in administering hormonal doses.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20275&type=smp

What Drivers Are Shaping The Future Growth Of The Rekovelle Market?

A projected expansion of the Rekovelle market is anticipated due to the rising occurrence of infertility. Infertility rates indicate the percentage of couples or individuals in a given population who cannot achieve conception after approximately one year of regular, unprotected sexual activity. Various factors contribute to the rise in infertility, including postponed parenthood, shifts in lifestyle, exposure to environmental pollutants, and certain health issues, which in turn fuels the need for fertility solutions. Rekovelle aids in mitigating infertility by boosting ovarian function and improving the efficacy of assisted reproductive methods such as IVF, thereby elevating the likelihood of successful fertilization and gestation. As an illustration, the World Health Organization, an intergovernmental entity based in Switzerland, reported in April 2023 that roughly 17.5% of adults worldwide, equating to about 1 in 6 people, experience infertility. Consequently, the escalating incidence of infertility is a key factor in the Rekovelle market’s growth. The rising occurrence of genetic conditions is anticipated to fuel the expansion of the Rekovelle market. Genetic conditions are health issues stemming from irregularities in an individual’s DNA, such as alterations, removals, or duplications. The increase in genetic conditions is linked to older parental age, which elevates the chances of DNA mutations in reproductive cells (eggs and sperm). Rekovelle assists individuals facing fertility difficulties associated with genetic factors by encouraging ovarian follicle growth for successful IVF procedures. For example, data from March 2024 by the Gene People, a registered charity located in the UK, indicates that genetic conditions impact approximately 1 in 25 children, affecting more than 2.4 million children and adults across the UK. Consequently, the growing incidence of genetic conditions is a significant factor in the expansion of the Rekovelle market.

What Segment Groups Are Identified Within The Rekovelle Market?

The rekovelle market covered in this report is segmented –

1) By Indication: Controlled Ovarian Stimulation, Polycystic Ovary Syndrome

2) By Distribution Channel: Hospitals, Clinics, Pharmacies

3) By End User: Pediatric, Adult, Geriatric

What Trends Are Advancing Progress In The Rekovelle Market?

Major companies operating in the Rekovelle market are prioritizing the development of innovative solutions, such as personalized ovarian stimulation, to satisfy the growing demand for more effective and safer fertility treatments. Personalized ovarian stimulation involves adapting the therapy, specifically the drug dosage, to each individual’s characteristics, including body weight and anti Müllerian hormone levels, instead of administering a standard dose to everyone. In March 2023, Ferring Pharmaceuticals A/S, a Switzerland-based pharmaceutical company, presented data from the PROFILE study, which was the first prospective, real-world study of Rekovelle (follitropin delta). The results demonstrated that approximately 74% of participants retrieved between 4 and 19 oocytes, and the ongoing pregnancy rates aligned with those observed in previous Phase 3 trials. An individualized dosing algorithm, based on body weight and AMH, was utilized in 95% of the cases. These findings substantiate Rekovelle’s efficacy and safety within a real-world, personalized ovarian stimulation context.

Which Companies Hold Significant Positions In The Rekovelle Market?

Major companies operating in the rekovelle market are Ferring Pharmaceuticals A/S

Read the full rekovelle market report here:

https://www.thebusinessresearchcompany.com/report/rekovelle-global-market-report

Which Geographic Regions Are Influencing Demand In The Rekovelle Market?

Europe was the largest region in the rekovelle market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rekovelle market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Rekovelle Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20275&type=smp

Browse Through More Reports Similar to the Global Rekovelle Market 2026, By The Business Research Company

Retinol Market Report 2026

https://www.thebusinessresearchcompany.com/report/retinol-global-market-report

Remicade Biosimilar Market Report 2026

https://www.thebusinessresearchcompany.com/report/remicade-biosimilar-global-market-report

Luxury Resale Market Report 2026

https://www.thebusinessresearchcompany.com/report/luxury-resale-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795